Study of transplant decisions, quality of life, and costs in Reunion
Part of Blood & lymphatic clinical trials.
This study looks at how having an allogeneic stem cell transplant affects quality of life, how patients make transplant decisions, and the financial impact—especially for people living on Réunion Island. It includes patients who are planning this transplant in mainland France and will answer questionnaires.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a blood cancer such as acute leukemia, lymphoma, Hodgkin disease, or myelodysplastic syndrome
- You are 18 or older
- You live on Réunion Island
- Your doctor is considering an allogeneic stem cell transplant in mainland France (using a donor’s cells)
- You are willing (or able) to complete questionnaires, and your data can be collected
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study checks how children who had a stem cell transplant for a primary immune deficiency are doing emotionally and mentally, at least 2 years after the transplant. It helps us understand the long-term effects of this treatment on children's health and development.
This study looks at how the immune system changes after an allogeneic stem cell transplant (using a donor’s stem cells). It may help researchers understand what controls immune recovery and transplant-related complications.
This study looks at how often certain BRCA2 gene changes occur in people in Réunion who have breast cancer. Your participation may help doctors understand breast cancer risk in the local community and guide future care.
This study follows adults who are being checked for a possible blood cancer, or who were recently diagnosed with a blood cancer within the last 6 months. It may help doctors understand the condition better and improve how early workups and care are organized.
This study invites adults who had a donor (allogeneic) transplant at KU Leuven long ago to share health information during a scheduled checkup. It may help researchers better understand long-term outcomes and support needs after transplant.
This study looks at how metabolism and infections affect people in La Réunion. Participants will provide consent for genetic analysis and answer health questions.
Hear when a new Allogeneic Hematopoietic Stem Cell Transplantation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.